{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:14:06Z","timestamp":1786119246922,"version":"build-2736575974"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1097\/gco.0b013e3283294770","type":"journal-article","created":{"date-parts":[[2009,5,21]],"date-time":"2009-05-21T07:24:24Z","timestamp":1242890664000},"page":"142-147","source":"Crossref","is-referenced-by-count":19,"title":["Prematurity prevention: the role of progesterone"],"prefix":"10.1097","volume":"21","author":[{"given":"Eduardo B","family":"da Fonseca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto E","family":"Bittar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rievani","family":"Dami\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo","family":"Zugaib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-7-20210129","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0140-6736(08)60108-7","article-title":"Primary, secondary, and tertiary interventions to reduce the morbidity and mortality of preterm birth","volume":"371","author":"Iams","year":"2008","journal-title":"Lancet"},{"key":"R2-7-20210129","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0140-6736(08)60074-4","article-title":"Epidemiology and causes of preterm birth","volume":"371","author":"Goldenberg","year":"2008","journal-title":"Lancet"},{"key":"R3-7-20210129","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1701-2163(16)32716-5","article-title":"The use of progesterone for prevention of preterm birth","volume":"30","author":"Farine","year":"2008","journal-title":"J Obstet Gynaecol Can"},{"key":"R4-7-20210129","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/AOG.0b013e31817d0262","article-title":"Progesterone for the prevention of preterm birth: a systematic review","volume":"112","author":"Dodd","year":"2008","journal-title":"Obstet Gynecol"},{"key":"R5-7-20210129","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/01.AOG.0000150559.59531.b2","article-title":"Progestational agents to prevent preterm birth: a meta-analysis of randomized controlled trials","volume":"105","author":"Sanchez-Ramos","year":"2005","journal-title":"Obstet Gynecol"},{"key":"R7-7-20210129","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.ajog.2006.06.013","article-title":"The use of progestational agents for preterm birth: lessons from a mouse model","volume":"195","author":"Elovitz","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"R8-7-20210129","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1080\/14767050801923680","article-title":"Medroxyprogesterone acetate modulates the immune response in the uterus, cervix and placenta in a mouse model of preterm birth","volume":"21","author":"Elovitz","year":"2008","journal-title":"J Matern Fetal Neonatal Med"},{"key":"R9-7-20210129","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.ajog.2008.01.029","article-title":"Preventing cervical ripening: the primary mechanism by which progestational agents prevent preterm birth?","volume":"198","author":"Xu","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"R10-7-20210129","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1055\/s-2006-956777","article-title":"Dynamics of cervical remodeling during pregnancy and parturition: mechanisms and current concepts","volume":"25","author":"Word","year":"2007","journal-title":"Semin Reprod Med"},{"key":"R12-7-20210129","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1471-0528.1989.tb02385.x","article-title":"A meta-analysis of randomized control trials of progestational agents in pregnancy","volume":"96","author":"Goldstein","year":"1989","journal-title":"Br J Obstet Gynaecol"},{"key":"R13-7-20210129","first-page":"692","article-title":"Inefficacy of 17 alpha-hydroxyprogesterone caproate in the prevention of prematurity in twin pregnancy","volume":"56","author":"Hartikainen-Sorri","year":"1980","journal-title":"Obstet Gynecol"},{"key":"R14-7-20210129","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1471-0528.1990.tb01740.x","article-title":"Progestogen administration in pregnancy may prevent preterm delivery","volume":"97","author":"Keirse","year":"1990","journal-title":"Br J Obstet Gynaecol"},{"key":"R15-7-20210129","first-page":"30","article-title":"Habitual abortion: a controlled study of progestational therapy","volume":"72","author":"LeVine","year":"1964","journal-title":"West J Surg Obstet Gynecol"},{"key":"R16-7-20210129","first-page":"198","article-title":"Hormonal therapy for control of the incompetent os of pregnancy","volume":"28","author":"Sherman","year":"1966","journal-title":"Obstet Gynecol"},{"key":"R17-7-20210129","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0002-9378(83)91051-7","article-title":"The effect of 17 alpha-hydroxyprogesterone caproate on pregnancy outcome in an active-duty military population","volume":"146","author":"Hauth","year":"1983","journal-title":"Am J Obstet Gynecol"},{"key":"R18-7-20210129","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1056\/NEJM197510022931401","article-title":"Efficacy of 17alpha-hydroxyprogesterone caproate in the prevention of premature labor","volume":"293","author":"Johnson","year":"1975","journal-title":"N Engl J Med"},{"key":"R19-7-20210129","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/0002-9378(85)90141-3","article-title":"Prevention of premature labor by 17 alpha-hydroxyprogesterone caproate","volume":"151","author":"Yemini","year":"1985","journal-title":"Am J Obstet Gynecol"},{"key":"R20-7-20210129","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1067\/mob.2003.41","article-title":"Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double-blind study","volume":"188","author":"da Fonseca","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"R21-7-20210129","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1056\/NEJMoa035140","article-title":"Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate","volume":"348","author":"Meis","year":"2003","journal-title":"N Engl J Med"},{"key":"R22-7-20210129","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1001\/jama.1964.03060330031008","article-title":"Double-blind trial of a progestin in habitual abortion","volume":"188","author":"Goldzieher","year":"1964","journal-title":"J Am Med Assoc"},{"key":"R23-7-20210129","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/S0140-6736(80)92496-4","article-title":"Progestagens in threatened abortion","volume":"2","author":"Tognoni","year":"1980","journal-title":"Lancet"},{"key":"R24-7-20210129","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1056\/NEJMoa070641","article-title":"A trial of 17 alpha-hydroxyprogesterone caproate to prevent prematurity in twins","volume":"357","author":"Rouse","year":"2007","journal-title":"N Engl J Med"},{"key":"R25-7-20210129","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/uog.5158","article-title":"Progesterone vaginal gel for the reduction of recurrent preterm birth: primary results from a randomized, double-blind, placebo-controlled trial","volume":"30","author":"O'Brien","year":"2007","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R26-7-20210129","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1056\/NEJMoa067815","article-title":"Progesterone and the risk of preterm birth among women with a short cervix","volume":"357","author":"Fonseca","year":"2007","journal-title":"N Engl J Med"},{"key":"R27-7-20210129","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/uog.5159","article-title":"Vaginal progesterone is associated with a decrease in risk for early preterm birth and improved neonatal outcome in women with a short cervix: a secondary analysis from a randomized, double-blind, placebo-controlled trial","volume":"30","author":"DeFranco","year":"2007","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R28-7-20210129","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/0002-9378(86)90595-8","article-title":"The potential tocolytic effect of natural progesterone administration on premature","volume":"154","author":"Erny","year":"1986","journal-title":"Am J Obstet Gynecol"},{"key":"R29-7-20210129","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0028-2243(91)90118-5","article-title":"The use of micronized progesterone in the treatment of menace of preterm delivery","volume":"40","author":"Noblot","year":"1991","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R30-7-20210129","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.ajog.2006.09.009","article-title":"Cervical length changes during preterm cervical ripening: effects of 17-alpha-hydroxyprogesterone caproate","volume":"196","author":"Facchinetti","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"R31-7-20210129","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1479-828X.2007.00803.x","article-title":"Progesterone for maintenance tocolytic therapy after threatened preterm labour: a randomised controlled trial","volume":"48","author":"Borna","year":"2008","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"R32-7-20210129","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.2337\/dc07-0564","article-title":"Increased incidence of gestational diabetes in women receiving prophylactic 17alpha-hydroxyprogesterone caproate for prevention of recurrent preterm delivery","volume":"30","author":"Rebarber","year":"2007","journal-title":"Diabetes Care"},{"key":"R33-7-20210129","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1001\/jama.1978.03290090031012","article-title":"Exogenous progestogen and estrogen implicated in birth defects","volume":"240","author":"Nora","year":"1978","journal-title":"J Am Med Assoc"},{"key":"R34-7-20210129","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1002\/bdra.20184","article-title":"Nongenital malformations following exposure to progestational drugs: the last chapter of an erroneous allegation","volume":"73","author":"Brent","year":"2005","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"R35-7-20210129","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/tera.1420350115","article-title":"Embryotoxicity of sex steroidal hormone combinations in nonhuman primates: I. Norethisterone acetate + ethinylestradiol and progesterone + estradiol benzoate (Macaca mulatta, Macaca fascicularis, and Papio cynocephalus)","volume":"35","author":"Hendrickx","year":"1987","journal-title":"Teratology"},{"key":"R36-7-20210129","first-page":"963","article-title":"Use of progesterone to reduce preterm birth.","volume":"419","year":"2008","journal-title":"Obstet Gynecol"},{"key":"R37-7-20210129","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1046\/j.1469-0705.1998.12050312.x","article-title":"Cervical length at 23 weeks of gestation: prediction of spontaneous preterm delivery","volume":"12","author":"Heath","year":"1998","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R38-7-20210129","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1002\/uog.893","article-title":"Transvaginal ultrasound in pregnancy: its acceptability to women and maternal psychological morbidity","volume":"22","author":"Clement","year":"2003","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R39-7-20210129","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/uog.5333","article-title":"Cervical length and obstetric history predict spontaneous preterm birth: development and validation of a model to provide individualized risk assessment","volume":"31","author":"Celik","year":"2008","journal-title":"Ultrasound Obstet Gynecol"}],"container-title":["Current Opinion in Obstetrics & Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/GCO.0b013e3283294770","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:46:12Z","timestamp":1786038372000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001703-200904000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/gco.0b013e3283294770","relation":{},"ISSN":["1040-872X"],"issn-type":[{"value":"1040-872X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,4]]}}}